US Stock MarketDetailed Quotes

FWBI First Wave BioPharma

Watchlist
  • 2.8400
  • -0.0600-2.07%
Close Apr 18 16:00 ET
5.75MMarket Cap-59P/E (TTM)

First Wave BioPharma Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
24.39%15.77M
79.57%4.09M
178.21%3.43M
-22.65%4.18M
-56.70%4.06M
-77.64%12.68M
-74.14%2.28M
-114.44%-4.39M
-41.73%5.41M
14.23%9.38M
Selling and administrative expenses
-10.42%10.74M
27.94%2.79M
-16.61%2.42M
13.19%2.83M
-38.70%2.7M
-34.80%11.99M
-28.28%2.18M
-51.76%2.9M
-31.14%2.5M
-22.68%4.41M
-General and administrative expense
-10.42%10.74M
27.94%2.79M
-16.61%2.42M
13.19%2.83M
-38.70%2.7M
-34.80%11.99M
-28.28%2.18M
-51.76%2.9M
-31.14%2.5M
-22.68%4.41M
Research and development costs
628.13%5.03M
1,183.99%1.31M
113.86%1.01M
-53.45%1.35M
-72.64%1.36M
-98.20%691.26K
-98.24%101.82K
-129.92%-7.29M
-48.53%2.91M
97.79%4.98M
Operating profit
-24.39%-15.77M
-79.57%-4.09M
-178.21%-3.43M
22.65%-4.18M
56.70%-4.06M
77.64%-12.68M
74.14%-2.28M
114.44%4.39M
41.73%-5.41M
-14.23%-9.38M
Net non-operating interest income expense
-167.04%-19.93K
-352.82%-6.82K
-156.69%-1.02K
-116.97%-4.97K
-30.15%-7.11K
25.82%-7.46K
-23.32%-1.51K
342.72%1.8K
22.41%-2.29K
-15.29%-5.47K
Non-operating interest income
-69.92%2.53K
-95.22%224
-91.40%229
-77.86%205
1,247.48%1.87K
617.39%8.42K
299.49%4.69K
--2.66K
--926
-65.51%139
Non-operating interest expense
41.46%22.46K
13.81%7.05K
44.84%1.25K
60.91%5.18K
60.34%8.99K
41.34%15.88K
158.58%6.19K
16.31%863
8.94%3.22K
8.96%5.61K
Other net income (expense)
99.78%-4.22K
99.97%-495
-2.62K
99.53%-1.11K
-6.65%-1.94M
27.65%-1.7M
-144.93%-239.3K
Special income (charges)
--0
----
----
----
----
27.24%-1.71M
----
----
----
----
-Gain on sale of business
--0
----
----
----
----
---1.71M
----
----
----
----
Other non- operating income (expenses)
98.19%-4.22K
-107.55%-495
----
---2.62K
99.53%-1.11K
-143.99%-232.74K
253.13%6.56K
----
----
-144.93%-239.3K
Income before tax
-7.97%-15.79M
-2.88%-4.1M
-178.20%-3.43M
22.54%-4.19M
57.72%-4.07M
75.01%-14.63M
64.32%-3.99M
114.44%4.39M
41.72%-5.41M
-25.26%-9.63M
Income tax
Net income
-7.97%-15.79M
-2.88%-4.1M
-178.20%-3.43M
22.54%-4.19M
57.72%-4.07M
75.01%-14.63M
64.32%-3.99M
114.44%4.39M
41.72%-5.41M
-25.26%-9.63M
Net income continuous Operations
-7.97%-15.79M
-2.88%-4.1M
-178.20%-3.43M
22.54%-4.19M
57.72%-4.07M
75.01%-14.63M
64.32%-3.99M
114.44%4.39M
41.72%-5.41M
-25.26%-9.63M
Minority interest income
Net income attributable to the parent company
-7.97%-15.79M
-2.88%-4.1M
-178.20%-3.43M
22.54%-4.19M
57.72%-4.07M
75.01%-14.63M
64.32%-3.99M
114.44%4.39M
41.72%-5.41M
-25.26%-9.63M
Preferred stock dividends
4.05%308.13K
3,827.32%77.08K
-55.30%49.29K
-2.88%94.32K
-3.70%87.43K
-98.86%296.13K
-101.78%-2.07K
-6.61%110.28K
-97.19%97.13K
-99.59%90.79K
Other preferred stock dividends
0
0
0
0
47.3K
0
47.3K
47.3K
Net income attributable to common stockholders
-7.55%-16.1M
-4.87%-4.18M
-182.28%-3.48M
22.85%-4.28M
57.21%-4.16M
82.28%-14.97M
64.71%-3.98M
113.87%4.23M
56.38%-5.55M
67.59%-9.72M
Basic earnings per share
88.52%-47.88
96.66%-2.6765
-102.49%-9.2
96.47%-37.8
90.79%-254.8
98.95%-416.94
-110.93%-80.0788
102.70%370.2
84.38%-1.07K
87.85%-2.77K
Diluted earnings per share
88.52%-47.88
96.66%-2.6765
-102.52%-9.2
96.47%-37.8
90.79%-254.8
98.95%-416.94
-110.93%-80.0788
102.66%364.6
84.38%-1.07K
87.85%-2.77K
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 24.39%15.77M79.57%4.09M178.21%3.43M-22.65%4.18M-56.70%4.06M-77.64%12.68M-74.14%2.28M-114.44%-4.39M-41.73%5.41M14.23%9.38M
Selling and administrative expenses -10.42%10.74M27.94%2.79M-16.61%2.42M13.19%2.83M-38.70%2.7M-34.80%11.99M-28.28%2.18M-51.76%2.9M-31.14%2.5M-22.68%4.41M
-General and administrative expense -10.42%10.74M27.94%2.79M-16.61%2.42M13.19%2.83M-38.70%2.7M-34.80%11.99M-28.28%2.18M-51.76%2.9M-31.14%2.5M-22.68%4.41M
Research and development costs 628.13%5.03M1,183.99%1.31M113.86%1.01M-53.45%1.35M-72.64%1.36M-98.20%691.26K-98.24%101.82K-129.92%-7.29M-48.53%2.91M97.79%4.98M
Operating profit -24.39%-15.77M-79.57%-4.09M-178.21%-3.43M22.65%-4.18M56.70%-4.06M77.64%-12.68M74.14%-2.28M114.44%4.39M41.73%-5.41M-14.23%-9.38M
Net non-operating interest income expense -167.04%-19.93K-352.82%-6.82K-156.69%-1.02K-116.97%-4.97K-30.15%-7.11K25.82%-7.46K-23.32%-1.51K342.72%1.8K22.41%-2.29K-15.29%-5.47K
Non-operating interest income -69.92%2.53K-95.22%224-91.40%229-77.86%2051,247.48%1.87K617.39%8.42K299.49%4.69K--2.66K--926-65.51%139
Non-operating interest expense 41.46%22.46K13.81%7.05K44.84%1.25K60.91%5.18K60.34%8.99K41.34%15.88K158.58%6.19K16.31%8638.94%3.22K8.96%5.61K
Other net income (expense) 99.78%-4.22K99.97%-495-2.62K99.53%-1.11K-6.65%-1.94M27.65%-1.7M-144.93%-239.3K
Special income (charges) --0----------------27.24%-1.71M----------------
-Gain on sale of business --0-------------------1.71M----------------
Other non- operating income (expenses) 98.19%-4.22K-107.55%-495-------2.62K99.53%-1.11K-143.99%-232.74K253.13%6.56K---------144.93%-239.3K
Income before tax -7.97%-15.79M-2.88%-4.1M-178.20%-3.43M22.54%-4.19M57.72%-4.07M75.01%-14.63M64.32%-3.99M114.44%4.39M41.72%-5.41M-25.26%-9.63M
Income tax
Net income -7.97%-15.79M-2.88%-4.1M-178.20%-3.43M22.54%-4.19M57.72%-4.07M75.01%-14.63M64.32%-3.99M114.44%4.39M41.72%-5.41M-25.26%-9.63M
Net income continuous Operations -7.97%-15.79M-2.88%-4.1M-178.20%-3.43M22.54%-4.19M57.72%-4.07M75.01%-14.63M64.32%-3.99M114.44%4.39M41.72%-5.41M-25.26%-9.63M
Minority interest income
Net income attributable to the parent company -7.97%-15.79M-2.88%-4.1M-178.20%-3.43M22.54%-4.19M57.72%-4.07M75.01%-14.63M64.32%-3.99M114.44%4.39M41.72%-5.41M-25.26%-9.63M
Preferred stock dividends 4.05%308.13K3,827.32%77.08K-55.30%49.29K-2.88%94.32K-3.70%87.43K-98.86%296.13K-101.78%-2.07K-6.61%110.28K-97.19%97.13K-99.59%90.79K
Other preferred stock dividends 000047.3K047.3K47.3K
Net income attributable to common stockholders -7.55%-16.1M-4.87%-4.18M-182.28%-3.48M22.85%-4.28M57.21%-4.16M82.28%-14.97M64.71%-3.98M113.87%4.23M56.38%-5.55M67.59%-9.72M
Basic earnings per share 88.52%-47.8896.66%-2.6765-102.49%-9.296.47%-37.890.79%-254.898.95%-416.94-110.93%-80.0788102.70%370.284.38%-1.07K87.85%-2.77K
Diluted earnings per share 88.52%-47.8896.66%-2.6765-102.52%-9.296.47%-37.890.79%-254.898.95%-416.94-110.93%-80.0788102.66%364.684.38%-1.07K87.85%-2.77K
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg